Sitagliptin/Metformin Merck 50 mg/850 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin/metformin merck 50 mg/850 mg film-coated tablets

merck healthcare kgaa frankfurter strasse 250, 64293 darmstadt, germany - sitagliptin, metformin hydrochloride - film-coated tablet - metformin hydrochloride 850 mg sitagliptin 50 mg - drugs used in diabetes

Sitagliptin / Metformin hydrochloride Sun European Union - English - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin.sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i.e., a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist.sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i.e., triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Sitagliptin/Metformin Merck 50 mg/1000 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin/metformin merck 50 mg/1000 mg film-coated tablets

merck healthcare kgaa frankfurter strasse 250, 64293 darmstadt, germany - sitagliptin, metformin hydrochloride - film-coated tablet - sitagliptin 50 mg metformin hydrochloride 1000 mg - drugs used in diabetes

SITAGLIPTIN/METFORMIN DOC 50 mg/850 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin/metformin doc 50 mg/850 mg film-coated tablets

doc generici srl via turati, 40-20121, milano, italy - sitagliptin, metformin hydrochloride - film-coated tablet - sitagliptin 50 mg metformin hydrochloride 850 mg - drugs used in diabetes

SITAGLIPTIN/METFORMIN DOC 50 mg/1000 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin/metformin doc 50 mg/1000 mg film-coated tablets

doc generici srl via turati, 40-20121, milano, italy - sitagliptin, metformin hydrochloride - film-coated tablet - sitagliptin 50 mg metformin hydrochloride 1000 mg - drugs used in diabetes

Sitagliptin/Metformin Rafarm 50 mg/850 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin/metformin rafarm 50 mg/850 mg film-coated tablets

rafarm s.a. 12, korinthou str., 15451 neo psihiko, athens, greece - sitagliptin, metformin hydrochloride - film-coated tablet - sitagliptin 50 mg metformin hydrochloride 850 mg - drugs used in diabetes

Sitagliptin / Metformin hydrochloride Accord European Union - English - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, type 2 - drugs used in diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin.it is indicated in combination with a sulphonylurea (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i.e., a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist.it is also indicated as add-on to insulin (i.e., triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Sitagliptin/Metformin Clonmel 50 mg/1000 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

sitagliptin/metformin clonmel 50 mg/1000 mg film-coated tablets

clonmel healthcare ltd - sitagliptin; metformin hydrochloride - film-coated tablet - 50 mg/1000 milligram(s) - metformin and sitagliptin

Sitagliptin/Metformin Clonmel 50 mg/850 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

sitagliptin/metformin clonmel 50 mg/850 mg film-coated tablets

clonmel healthcare ltd - sitagliptin; metformin hydrochloride - film-coated tablet - 50 mg/850 milligram(s) - metformin and sitagliptin

Sitagliptin/Metformin Galenicum 50 mg/850 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin/metformin galenicum 50 mg/850 mg film-coated tablets

galenicum health, s.l. avenida diagonal 123, 11ª planta, 08005, barcelona, spain - sitagliptin, metformin hydrochloride - film-coated tablet - sitagliptin 50 milligram(s) ; metformin hydrochloride 850 milligram(s) - drugs used in diabetes